Breast cancer is the most common type of cancer among women worldwide. The standard histopathology of breast tissue, the primary means of disease diagnosis, involves manual microscopic examination of stained tissue by a pathologist. Because this method relies on qualitative information, it can result in inter-observer variation. Furthermore, for difficult cases the pathologist often needs additional markers of malignancy to help in making a diagnosis. We present a quantitative method for label-free tissue screening using Spatial Light Interference Microscopy (SLIM). By extracting tissue markers of malignancy based on the nanostructure revealed by the optical path-length, our method provides an objective and potentially automatable method for rapidly flagging suspicious tissue. We demonstrated our method by imaging a tissue microarray comprising 68 different subjects -34 with malignant and 34 with benign tissues. Three-fold cross validation results showed a sensitivity of 94% and specificity of 85% for detecting cancer. The quantitative biomarkers we extract provide a repeatable and objective basis for determining malignancy. Thus, these disease signatures can be automatically classified through machine learning packages, since our images do not vary from scan to scan or instrument to instrument, i.e., they represent intrinsic physical attributes of the sample, independent of staining quality.
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Introduction:
The latest World Health Organization (WHO) figures have reported breast cancer as the second most common form of cancer worldwide with 522,000 deaths in 2012
1 . Within the US over 200,000 new cases of the disease are expected for women in 2017 according to the American Cancer Society 2 . Effective treatment strategies require timely and accurate diagnosis of the disease. It has been reported that, in the US, the 5-year average survival rates for patients with invasive breast cancers increase from 90% to 99% when the disease is detected at a localized (non-metastatic) stage 3 .
The standard tissue evaluation method for diagnosing breast cancers involves microscopic examination of a hematoxylin and eosin (H&E) counter-stained tissue biopsy. The biopsy specimen is obtained from the patient when suspicion of disease is noted during a screening procedure such as X-ray mammography. Since cells and histological tissue sections are transparent, the H&E stain provides the necessary contrast for assessing tissue morphology using a conventional bright field microscope. This standard histopathology process has two important short-comings: reliance on qualitative markers leads to intra-and inter-observer variation while manual examination can lower the throughput of the evaluation. Quantitative microscopy could help pathologists by offering an objective assessment of the tissue physical
properties. Furthermore, quantitative markers can be interpreted by machine learning classifiers for rapid analysis and automated detection 4 .
In this work, we present a method for extracting quantitative markers of malignancy in breast tissue biopsies using Spatial Light Interference Microscopy (SLIM) 5 . SLIM is a quantitative phase imaging (QPI) 6 modality that generates contrast by measuring the variation of optical path-length difference (OPD) across the tissue specimen. OPD reports on the product of the refractive index and thickness of tissue at each pixel. Malignant transformation involves physical changes in epithelial cell size and density as well as the tissue organization -both of which affect OPD maps of tissue. 
b. Tissue microarray
The TMA used for our study was purchased from US Biomax Inc. (Serial # BR-1002) with diagnosis for each case provided by the manufacturer. 
c. Annotation of epithelial regions in tissue images
Glands or continuous epithelial regions within each core were manually annotated using the region of interest (ROI) tool of ImageJ to allow feature extraction for each gland. A consistent criterion for annotation was used where groups of epithelial cells bounded by stroma on all sides where considered a single gland. Other tissue components within epithelium (such as lumen etc.) were considered part of the gland if bounded on all sides by epithelial cells. Glands from cores in the IDC cohort were labelled as malignant while those from cores in the tumor adjacent normal cohort were labelled as benign.
d. Extraction of geometric and scattering features
Malignant transformation in breast tissue affects the size, shape and density of epithelial cells as well as the shape and organization of epithelial tissue. As a result, both the geometry and scattering properties of the gland are affected. We used gland perimeter curvature C , as well as the mean scattering length s l as part of the feature set used for separating benign and malignant tissue. The parameter extraction process is illustrated in Fig. 2 and a detailed description for each is provided below.
The extrinsic curvature C of a two-dimensional plane curve ( , ) P x y , that is parametrized by Cartesian coordinates ( ) x t and ( ) y t with parameter t , is given by the expression
where the ' x , ' y and '' x , '' y refer to the first and second derivatives in t , respectively. In the above parametrization, t refers to each pixel comprising the curve ( , ) P x y , having coordinates The mean scattering length s l is a bulk scattering parameter that defines the length scale over which a single scattering event occurs on average. Assuming that the tissue slice captures the refractive index spatial fluctuation statistics, i.e., assuming statistical homogeneity, s l can be computed through the scattering-phase theorem using the expression
where ( scattering and texture-related features. This procedure is illustrated in Fig. 4 . After pixel-wise computation of gland curvature C , scattering length s l and texture vector T , the median of each feature was computed over each gland in a core and a combined 52 dimension feature vector was generated for training. For each gland, this feature vector was then used as a predictor for training a linear-discriminant analysis (LDA) classifier [ Fig. 4(a) ]. Class labels, either benign or malignant, were used as the ground-truth for each gland during the training process.
The feature extraction for validation purposes, illustrated in Fig. 4 (b) , followed a nearly identical procedure to that used during training. The only difference was that, instead of finding new textons (cluster centroids) for validation data, the texture feature vector T was computed by using the same textons as determined during training. As in training, a 52 dimensional feature vector was input to the LDA classifier which then used the model learned during training to generate a likelihood score for a gland being benign or malignant. Finally, the mean of the likelihood scores of all glands within a core was computed and used as the likelihood score of a core being benign or malignant. These scores were then used to generate a receiver operative characteristic (ROC) to select an operating point for separating benign and malignant cases (see Results and Discussion). 
Results and Discussion
The classification results of our analysis are summarized in Fig. 5 . In order to evaluate the accuracy of our method, we performed three-fold cross-validation 50 as illustrated in Fig. 5 (a). The total number of cases were divided into three (nearly) equal groups. In each trial, two groups were used for training while the remaining one was used for validation. Thus, three validation trials were performed, each time selecting a different validation/training set combination. This geometric feature is similar to the previous measurement of the gland perimeter fractal dimension that has been used for histopathology 21, 27 . Fig. 5 (c) shows the separation between benign and malignant glands in the validation feature space, where, qualitatively, the same separation trend is seen as in training. We show the results of only one of the three validation trials that were carried out. As described in Materials and Methods, the gland likelihood scores, generated by the classifier during validation, were averaged over each gland in order to obtain core-wise or case-wise scores. The core-wise likelihood scores from the 3 trials were then pooled together to generate the ROC curve 
Summary and Conclusions
In summary, we presented a new method for screening tissue biopsies obtained from patients under investigation for breast cancer. Since our method relies on measurement of OPD maps, an intrinsic property of tissue, the basis for classification is objective and not subject to inter-observer variation. While in the past much of the quantitative histopathology has relied on analysis of stained tissue, our method performs image processing and machine learning on unlabeled images, making it insensitive to variability due to staining. Thus, the process of automating the entire method is feasible and subject to our future efforts.
While other label-free diagnosis methods have been proposed for these types of investigations, they affect the standard diagnostic pipeline in terms of either speed, resolution or compatibility with established workflow. SLIM, on the other hand, requires minimal changes to a conventional microscopic optical train due to its modular design. Equipped with a slidescanning feature for rapid acquisition, a SLIM tissue scanner can potentially carry out highthroughput automated histopathology, not only reducing the case-load for pathologists but also providing complementary information through new markers. This carries the potential for incorporation into daily practice of diagnostic surgical pathology, either as a screening method to point out areas of the slide that need additional attention, or for difficult cases where pathologists need supporting tests to make a final diagnostic decision.
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